The ethical choice
For immediate release

Clinical Study Indicates Enterosgel is Effective Supportive Treatment for Cancer Patients

Preliminary results from a clinical study [1] indicate that an over-the-counter intestinal adsorbent called Enterosgel can be recommended as a supportive treatment during pelvic radiation in patients with uterine and cervical cancer. This is because it effectively reduces gastrointestinal problems and weight loss and is well tolerated.

It The report states that the most common adverse reactions of external pelvic radiotherapy include: frequent stools, frequent urination, dysuria, tenesmus, abdominal pain and blood count changes, and to reduce them, patients should mind their diet, take enough fluids and use medications. The researchers tested the effectiveness of the intestinal adsorbent Enterosgel.

Enterosgel is a clinically proven natural drug-free gel for adjuvant treatment of diarrhoea, gut health, allergies and IBS. It is recommended by World Health Organisation specialists in cases of food poisoning (botulism). The active substance of Enterosgel is an organosilicon compound – polymethylsiloxane polyhydrate (methylsilicic acid hydrogel). It has a porous structure, and a gel-like consistency. It is not synthetically produced – it’s an organic mineral, a stone that comes from the earth and is naturally occurring on the planet. It is then polymerised and mixed with water.

Enterosgel was administered as a part of the clinical study, ‘The role of Enterosgel in prevention of gastrointestinal adverse reactions of percutaneous radiation’. 90 patients with uterine or cervical cancer, treated by external pelvic radiotherapy, were divided into 2 groups: 46 patients who were given 45g of Enterosgel per day, and a second group of 44 patients who didn’t take Enterosgel. The following parameters were monitored: ECOG, body weight, diarrhoea, nausea, leukocytes, thrombocytes and erythrocytes count and potassium and sodium levels.

There was no statistically significant difference between the two groups for blood count, electrolytes levels and ECOG. However, there was a statistically significant difference for body weight, number of diarrhoeal stools and number of days without nausea. Compared to patients who weren’t taking Enterosgel, patients in the Enterosgel group lost 0.49 to 2.17 kg less weight, had 0.47 to 6.29 less diarrhoeal stools, and had 1.03 to 5.71 less days with nausea.

The report concluded that preliminary results indicate that Enterosgel can be recommended as a supportive treatment during pelvic radiation, because it is well tolerated and effectively reduces gastrointestinal problems and weight loss. It recommended additional studies including more patients.

Enterosgel® is available in both convenient sachets and tubes (225 g), priced from £12.80, at Boots, Superdrug, Lloyds Pharmacy, Holland & Barrett, DayLewis and other pharmacies and health stores.

NOTES TO EDITORS

References
[1] ‘Enterosorption as a supportive treatment during external radiotherapy in patients with uterine and cervical cancer’ – Višnja Matković1, Kristina Katić1, Ante Ćorušić1, Robert Likić2
1 Department of gynaecologic oncology, Clinic for Obstetrics and Gynecology, University Hospital Centre Zagreb, Zagreb
2 Department of Clinical Pharmacology, University Hospital Centre Zagreb, Zagreb, 6th November 2016.

About Enterosgel®
Enterosgel® is registered as a class IIA medical device, patent of Swiss company Bioline AG.

Enterosgel® is an intestinal adsorbent, composed of minerals and water and has high capacity to attach to its pores the medium-weight molecular substances in the gut, like endo-toxins and pathogens, which are then naturally expelled with the stool. It has no systemic side effects. It is completely non-allergenic, free from preservatives and taken orally diluted with water, has no taste or colour.

ENDS

PR Newsroom - Enterosgel oral suspension
Further information
For further information about thestudy, Enterosgel, or for product images, please contact:
Ian & Jenny Liddle, Excellart, 01450 219 246,
info@excellart.co.uk, www.facebook.com/Excellart, www.twitter.com/excellart

Home
About Us
Marketing & Design
PR Newsroom
Public Relations
Training & Advice
Contact Us
Previous Press Release
Next Press Release
PR Newsroom
Events:
West Midlands Vegan Festival
Experts:
Max Wiseberg (airborne allergies)
Howard Carter (bite prevention)
Daniel Brash (pharmacist)
Julie Silver (nutritional therapist)
Martin Fodor (green & eco issues)
Natural Health & Beauty:
HayMax
incognito
Enterosgel
Cisca Saltpipe

Qu-Chi
HealthCare4All
Food:
Julie Silver
+44 (0) 1450 219246